Quality research. Outstanding publications. With an impact factor of 3.225 (2016), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. ChemMedChem is made in Europe, but publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs.
ChemMedChem publishes an attractive mixture of:
- Full Papers and Communications
- Reviews and Minireviews
- Patent Reviews
- Highlights and Concepts
- Book and Multimedia Reviews
ChemMedChem is a journal of ChemPubSoc Europe. The ChemPubSoc Europe family comprises: Angewandte Chemie, Chemistry—A European Journal, European Journal of Organic Chemistry, European Journal of Inorganic Chemistry, ChemPhysChem, ChemBioChem, ChemMedChem, ChemCatChem, ChemSusChem, ChemPlusChem, ChemistryOpen, ChemistrySelect and ChemPhotoChem.